Analysis from market research group Frost & Sullivan indicates that the global market for gamma cameras will be constrained by the lack of new imaging agents that would open up new clinical applications for the systems, and by competition for budget and resources from PET, according to the San Jose, CA-based firm.
However, the company believes that gamma cameras also have a key advantage compared with PET imaging, namely their much larger worldwide installed base and the availability of longer half-life radioisotopes. The company said the market could experience greatly accelerated growth pending the availability of new diagnostic or therapeutic agents and clinical adoption of hybrid SPECT/CT imaging systems.
In its report, Strategic Analysis of Global Gamma Camera Markets, the firm said that the global gamma camera market generated revenues of $638 million in 2003, and is expected to grow at a compound annual growth rate of 3.1% to $788.8 million in 2010.By AuntMinnie.com staff writers
July 6, 2004
Copyright © 2004 AuntMinnie.com